Recombinant IL17RA (Brodalumab Biosimilar) antibody

Catalog No. ABIN7597569

This Human Monoclonal antibody specifically detects IL17RA (Brodalumab Biosimilar) in . It exhibits reactivity toward Human.

Quick Overview for Recombinant IL17RA (Brodalumab Biosimilar) antibody (ABIN7597569)

Target: IL17RA (Brodalumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL17RA (Brodalumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL17RA (Brodalumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Brodalumab Biosimilar Antibody

Specificity: IL17R, CDw217, IL-17RA, Interleukin-17 receptor A, IL-17 receptor A, IL17RA, CD217

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG2 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL17RA (Brodalumab Biosimilar)

Target: IL17RA (Brodalumab Biosimilar)

Alternative Name: Brodalumab Biosimilar

Target Type: Biosimilar

Background: IL17R, CDw217, IL-17RA, Interleukin-17 receptor A, IL-17 receptor A, IL17RA, CD217

UniProt: Q96F46

CAS-No: 1174395-19-7